mp.weixin.qq.com·· 8 hours agoPickScore85
EQT Takes Qiagen Private at EUR 10.8 Billion Enterprise Value; Molecular Diagnostics Leader to Delist
In brief
EQT is acquiring Qiagen through an all-cash offer of EUR 46.50 per share, valuing its equity at about EUR 9.6 billion (about USD 10.8 billion). The deal implies an enterprise value of about EUR 10.8 billion (about USD 12.1 billion), including about EUR 1.1 billion of net debt, at a 40.3% premium. After closing, Qiagen will be delisted from the Frankfurt Stock Exchange and the New York Stock Exchange.
Why it matters
The brief gives equity value, enterprise value, per-share price and premium, letting readers benchmark against comparable diagnostics leaders.
Source: mp.weixin.qq.com · mp.weixin.qq.com